Fidelity Investments’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.7K | Buy |
3,812
+1,253
| +49% | +$9.44K | ﹤0.01% | 4141 |
|
|
2025
Q1 | $19.4K | Sell |
2,559
-40,233
| -94% | -$305K | ﹤0.01% | 4232 |
|
|
2024
Q4 | $521K | Buy |
42,792
+22,432
| +110% | +$273K | ﹤0.01% | 2910 |
|
|
2024
Q3 | $341K | Buy |
20,360
+19,681
| +2,899% | +$329K | ﹤0.01% | 2999 |
|
|
2024
Q2 | $11.8K | Buy |
679
+153
| +29% | +$2.67K | ﹤0.01% | 4267 |
|
|
2024
Q1 | $8.96K | Buy |
526
+84
| +19% | +$1.43K | ﹤0.01% | 4314 |
|
|
2023
Q4 | $4.5K | Sell |
442
-1,132
| -72% | -$11.5K | ﹤0.01% | 4480 |
|
|
2023
Q3 | $14.2K | Sell |
1,574
-53,348
| -97% | -$483K | ﹤0.01% | 3972 |
|
|
2023
Q2 | $591K | Buy |
54,922
+650
| +1% | +$6.99K | ﹤0.01% | 2605 |
|
|
2023
Q1 | $555K | Sell |
54,272
-34,114
| -39% | -$349K | ﹤0.01% | 2657 |
|
|
2022
Q4 | $932K | Sell |
88,386
-41,148
| -32% | -$434K | ﹤0.01% | 2559 |
|
|
2022
Q3 | $1.66M | Sell |
129,534
-84,532
| -39% | -$1.08M | ﹤0.01% | 2477 |
|
|
2022
Q2 | $2.74M | Sell |
214,066
-1,415,114
| -87% | -$18.1M | ﹤0.01% | 2408 |
|
|
2022
Q1 | $17.1M | Buy |
1,629,180
+689,140
| +73% | +$7.22M | ﹤0.01% | 1855 |
|
|
2021
Q4 | $14.5M | Sell |
940,040
-1,560,172
| -62% | -$24.1M | ﹤0.01% | 1968 |
|
|
2021
Q3 | $56.4M | Buy |
2,500,212
+522,305
| +26% | +$11.8M | ﹤0.01% | 1361 |
|
|
2021
Q2 | $50.9M | Buy |
1,977,907
+757,733
| +62% | +$19.5M | ﹤0.01% | 1420 |
|
|
2021
Q1 | $50.8M | Buy |
+1,220,174
| New | +$50.8M | ﹤0.01% | 1393 |
|